Hisamitsu Pharmaceutical Co., Inc. (TYO: 4530)

Hisamitsu Pharmaceutical Co. Balance Sheet

Financials in millions JPY. Fiscal year is March - February.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 31, 2024	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020
Cash & Equivalents	113,572	112,459	122,154	129,290	114,254	107,051
Short-Term Investments	9,164	12,862	14,714	13,141	21,743	34,878
Cash & Short-Term Investments	122,736	125,321	136,868	142,431	135,997	141,929
Cash Growth	-13.22%	-8.44%	-3.91%	4.73%	-4.18%	8.15%
Receivables	51,576	42,983	39,753	38,112	39,203	48,907
Inventory	23,004	21,176	18,922	16,412	18,568	15,458
Other Current Assets	9,727	4,542	3,631	3,221	4,293	2,957
Total Current Assets	207,043	194,022	199,174	200,176	198,061	209,251
Property, Plant & Equipment	58,828	49,462	43,209	39,069	37,354	38,596
Long-Term Investments	78,151	76,813	69,244	61,133	62,220	56,796
Goodwill	1,369	1,444	-	-	-	-
Other Intangible Assets	5,085	5,387	946	1,326	1,178	1,469
Long-Term Deferred Tax Assets	-	1,649	1,342	1,153	1,047	1,287
Other Long-Term Assets	1	2	2	1	1	2
Total Assets	350,477	328,779	313,917	302,858	299,861	307,401
Accounts Payable	22,058	16,263	14,918	13,225	14,799	19,024
Accrued Expenses	1,345	1,831	1,340	1,363	1,350	1,558
Short-Term Debt	1,071	1,071	1,071	1,071	1,111	1,209
Current Portion of Leases	-	350	327	301	101	68
Current Income Taxes Payable	3,775	9,861	8,587	9,623	7,242	13,610
Other Current Liabilities	30,354	16,562	16,335	6,577	5,454	5,586
Total Current Liabilities	58,603	45,938	42,578	32,160	30,057	41,055
Long-Term Debt	46	76	147	219	296	368
Long-Term Leases	-	603	750	869	94	130
Long-Term Deferred Tax Liabilities	-	4,518	1,813	4,170	5,125	2,978
Other Long-Term Liabilities	7,240	1,967	1,815	2,339	2,553	4,526
Total Liabilities	74,552	61,700	55,511	47,973	46,053	56,657
Common Stock	8,473	8,473	8,473	8,473	8,473	8,473
Additional Paid-In Capital	2,361	2,361	2,361	2,356	2,352	2,272
Retained Earnings	248,509	242,578	235,569	236,192	233,376	230,929
Treasury Stock	-45,896	-36,993	-27,196	-19,527	-11,495	-11,730
Comprehensive Income & Other	60,126	48,455	37,157	25,674	19,592	19,330
Total Common Equity	273,573	264,874	256,364	253,168	252,298	249,274
Minority Interest	2,352	2,205	2,042	1,717	1,510	1,470
Shareholders' Equity	275,925	267,079	258,406	254,885	253,808	250,744
Total Liabilities & Equity	350,477	328,779	313,917	302,858	299,861	307,401
Total Debt	1,117	2,100	2,295	2,460	1,602	1,775
Net Cash (Debt)	121,619	123,221	134,573	139,971	134,395	140,154
Net Cash Growth	-13.28%	-8.44%	-3.86%	4.15%	-4.11%	8.36%
Net Cash Per Share	1616.45	1600.21	1694.75	1722.30	1643.25	1704.10
Filing Date Shares Outstanding	73.34	75.74	77.77	79.74	81.76	81.66
Total Common Shares Outstanding	73.34	75.74	77.74	79.74	81.73	81.66
Working Capital	148,440	148,084	156,596	168,016	168,004	168,196
Book Value Per Share	3730.06	3497.00	3297.53	3175.01	3086.80	3052.45
Tangible Book Value	267,119	258,043	255,418	251,842	251,120	247,805
Tangible Book Value Per Share	3642.06	3406.82	3285.36	3158.38	3072.39	3034.46

Source: S&P Capital IQ. Standard template. Financial Sources.